The Brutality of the Investment Landscape
September 11, 2025
Michael Murray has spent decades advising on deal management and commercial strategy – and he has a lot of tips and advice for budding start-ups looking for investment.
11 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Sustainability is Good Business: An Interview with Astellas
We speak with Adam Pearson, Chief Strategy Officer at Astellas, about the business of being green, success stories in Ireland, and helping local communities.
Latest News
All the latest Medicine Maker articles.
Tightened Surveillance: Inside the FDA’s Quality Enforcement Report
September 9, 2025
A surge in inspections, a spike in warning letters, and targeted action against high-risk sectors: the FDA’s 2024 report shows global pharma quality is under sharper scrutiny than ever.
4 min read
A Call for Coordinated Action to Protect mRNA R&D
September 9, 2025
Researchers call for urgent action to protect the future of mRNA vaccine development
2 min read
Stem Cell Library Lets Researchers Build Autism in the Lab
September 9, 2025
Researchers engineer 63 embryonic stem cell lines to study genetic variations tied to autism spectrum disorders.
4 min read
CRISPR and Cleaner: Gene Editing with Deep-Learning
September 8, 2025
By predicting how cells repair DNA, researchers find a way to make CRISPR edits more precise.
3 min read
The Multifaceted Future of Pharma – Chapter 11: The Manufacturing Challenges of Advanced Therapies
September 8, 2025
As cell and gene therapies become more commonplace, focus has now moved onto manufacturing efficiency and improving access for patients.
15 min read
Can Biotech Crack the AMR Dilemma? Let’s Hope So
September 5, 2025
Rocket launcher antibiotics, subscription models, and articulating value; we discuss new progress in antimicrobial therapies with Michael Murray
9 min read
A Non-Complex, Non-Toxic Method of Delivering Biologic Therapies
September 5, 2025
Meet the drug-delivery nanoparticles that self-assemble with temperature changes.
3 min read
Rotavirus Co-Inventor Removed From FDA Vaccine Committee
September 4, 2025
Paul Offit, a longtime FDA advisor and prominent figure in vaccine development, sidelined from vaccine committee amid healthcare turmoil in the US.
2 min read
Improving the Accessibility of CAR T-Cell Therapy
September 4, 2025
An international steering committee launched earlier in 2025 to improve access to CAR T-cell therapies for cancer patients. A cell therapy research specialist shares her reasons why.
9 min read
Regulators Sound Alarm on Dangers of Unapproved and Illicit GLP-1 Drugs
September 4, 2025
Increasing demand for GLP-1s sparks surge in illegal distribution
2 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.